Connecting the Metabolic and Immune Responses to Cancer

被引:51
作者
Flint, Thomas R. [1 ,2 ]
Fearon, Douglas T. [1 ,3 ,4 ]
Janowitz, Tobias [1 ,5 ]
机构
[1] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England
[2] Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Cambridge CB2 0SP, England
[3] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA
[4] Weill Cornell Med Coll, New York, NY 10021 USA
[5] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England
基金
英国惠康基金;
关键词
CELL LUNG-CANCER; SKELETAL-MUSCLE UCP2; WHITE ADIPOSE-TISSUE; ANTITUMOR IMMUNITY; GENE-EXPRESSION; PD-1; BLOCKADE; WEIGHT-LOSS; ANTI-PD-L1; ANTIBODY; ACTRIIB ANTAGONISM; CTLA-4;
D O I
10.1016/j.molmed.2017.03.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Separate research fields have advanced our understanding of, on the one hand, cancer immunology and, on the other hand, cachexia, the fatal tumor-induced wasting syndrome. A link between the host's immune and metabolic responses to cancer remained unexplored. Emerging work in preclinical models of colorectal and pancreatic cancer has unveiled tumor-induced reprogramming of liver metabolism in cachexia that leads to suppression of antitumor immunity and failure of immunotherapy. As research efforts in metabolism and immunology in cancer are rapidly expanding, it is timely to discuss the metabolic and immunological determinants of the cancer-host interaction. We also present the hypothesis that the convergence of host metabolism and antitumor immunity may offer a platform for biomarker-driven investigations of new combination therapies.
引用
收藏
页码:451 / 464
页数:14
相关论文
共 134 条
[1]   The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity [J].
Akpan, I. ;
Goncalves, M. D. ;
Dhir, R. ;
Yin, X. ;
Pistilli, E. E. ;
Bogdanovich, S. ;
Khurana, T. S. ;
Ucran, J. ;
Lachey, J. ;
Ahima, R. S. .
INTERNATIONAL JOURNAL OF OBESITY, 2009, 33 (11) :1265-1273
[2]   Association between CD8+T-cell infiltration and breast cancer survival in 12 439 patients [J].
Ali, H. R. ;
Provenzano, E. ;
Dawson, S-J ;
Blows, F. M. ;
Liu, B. ;
Shah, M. ;
Earl, H. M. ;
Poole, C. J. ;
Hiller, L. ;
Dunn, J. A. ;
Bowden, S. J. ;
Twelves, C. ;
Bartlett, J. M. S. ;
Mahmoud, S. M. A. ;
Rakha, E. ;
Ellis, I. O. ;
Liu, S. ;
Gao, D. ;
Nielsen, T. O. ;
Pharoah, P. D. P. ;
Caldas, C. .
ANNALS OF ONCOLOGY, 2014, 25 (08) :1536-1543
[3]   Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice [J].
Allen, David L. ;
Cleary, Allison S. ;
Lindsay, Sarah F. ;
Loh, Amanda S. ;
Reed, Jason M. .
JOURNAL OF APPLIED PHYSIOLOGY, 2010, 109 (03) :692-701
[4]   KETONE INFUSION LOWERS HORMONAL RESPONSES TO HYPOGLYCEMIA - EVIDENCE FOR ACUTE CEREBRAL UTILIZATION OF A NON-GLUCOSE FUEL [J].
AMIEL, SA ;
ARCHIBALD, HR ;
CHUSNEY, G ;
WILLIAMS, AJK ;
GALE, EAM .
CLINICAL SCIENCE, 1991, 81 (02) :189-194
[5]   Cancer cachexia: understanding the molecular basis [J].
Argiles, Josep M. ;
Busquets, Silvia ;
Stemmler, Britta ;
Lopez-Soriano, Francisco J. .
NATURE REVIEWS CANCER, 2014, 14 (11) :754-762
[6]  
Bing C, 2000, CANCER RES, V60, P2405
[7]   Cachexia in MAC16 adenocarcinoma: Suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y [J].
Bing, C ;
Taylor, S ;
Tisdale, MJ ;
Williams, G .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (05) :1004-1012
[8]   JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia [J].
Bonetto, Andrea ;
Aydogdu, Tufan ;
Jin, Xiaoling ;
Zhang, Zongxiu ;
Zhan, Rui ;
Puzis, Leopold ;
Koniaris, Leonidas G. ;
Zimmers, Teresa A. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2012, 303 (03) :E410-E421
[9]   STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia [J].
Bonetto, Andrea ;
Aydogdu, Tufan ;
Kunzevitzky, Noelia ;
Guttridge, Denis C. ;
Khuri, Sawsan ;
Koniaris, Leonidas G. ;
Zimmers, Teresa A. .
PLOS ONE, 2011, 6 (07)
[10]   Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].
Brahmer, Julie R. ;
Tykodi, Scott S. ;
Chow, Laura Q. M. ;
Hwu, Wen-Jen ;
Topalian, Suzanne L. ;
Hwu, Patrick ;
Drake, Charles G. ;
Camacho, Luis H. ;
Kauh, John ;
Odunsi, Kunle ;
Pitot, Henry C. ;
Hamid, Omid ;
Bhatia, Shailender ;
Martins, Renato ;
Eaton, Keith ;
Chen, Shuming ;
Salay, Theresa M. ;
Alaparthy, Suresh ;
Grosso, Joseph F. ;
Korman, Alan J. ;
Parker, Susan M. ;
Agrawal, Shruti ;
Goldberg, Stacie M. ;
Pardoll, Drew M. ;
Gupta, Ashok ;
Wigginton, Jon M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465